Researchers from the University of Illinois have demonstrated the importance of cell-type-specific targeting in the treatment of HIV. Their study, published in the Proceedings of the National Academy ...

Boston Medical Center has been using a new HIV molecular test as part of a series of tests used to diagnose and confirm HIV infection from a patient's blood. Published in the American Journal of ...

The first (particularly infective and virulent) type discovered, labeled HIV-1, is the predominant cause of AIDS worldwide. But further research identified a less virulent and less easily transmitted ...

Sunlenca (lenacapavir) is a medicine that was approved by the FDA in 2022 to treat HIV in combination with other HIV medicines. Sunlenca has a unique mechanism of action and is the first medicine in ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced approval of lenacapavir, a new antiretroviral medication for adults with HIV type 1 who cannot ...